HR 6102
116th Congress
House
Health
Administrative law and regulatory procedures
Administrative remedies
Advisory bodies
Congressional oversight
Department of Health and Human Services
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Federal preemption
Food and Drug Administration (FDA)
Government information and archives
Health technology, devices, supplies
Licensing and registrations
Medical tests and diagnostic methods
Performance measurement
User charges and fees
VALID Act of 2020
Everywhere this bill has been
2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 5, 2020
Referred to the House Committee on Energy and Commerce.
Mar 5, 2020
Introduced in House
Plain-English summary
Verifying Accurate Leading-edge IVCT Development Act of 2020 or the VALID Act of 2020
This bill requires the Food and Drug Administration to regulate in vitro clinical tests (i.e., tests intended for the collection, preparation, analysis, or in vitro clinical examination of specimens from the human body in order to provide information about a disease, condition, or treatment for a disease or condition).
What's happening now
Referred to the House Committee on Energy and Commerce.
Committees of jurisdiction
1